Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-20-015351

Chief Operations Officer acquired 75,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Newell Joe Chief Operations Officer 2020-03-01 Grant or award +75,000 128,881 D
Derivatives
Newell Joe Chief Operations Officer 2020-03-01 Grant or award · Employee Stock Option (Right to Buy) +53,000 53,000 D
Newell Joe Chief Operations Officer 2020-03-01 Grant or award · Employee Stock Option (Right to Buy) +17,000 17,000 D
Loading xslF345X03/doc4.xml…